SCHEMBL4560574

SCHEMBL4560574

CC(CCc1ccccc1)(C(N)=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
KMT2A Q03164 2/20 0.52
KIF11 P52732 1/20 0.46
ALDH1A1 P00352 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
RECQL P46063 1/20 0.42
CYP2C19 P33261 1/20 0.42
HIF1A Q16665 1/20 0.42
POLB P06746 1/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
OPRM1 P35372 1/20 0.41
DRD3 P35462 1/20 0.41
KEAP1 Q14145 1/20 0.41
LMNA P02545 2/20 0.41
CHRM2 P08172 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4559947 0.90 MAPT (0.49) MAPTKMT2AKIF11ALDH1A1NPC1
SCHEMBL2845811 0.82 MAPT (0.55) MAPTKMT2AKIF11ALDH1A1CYP1A2
SCHEMBL528412 0.82 KMT2A (0.55) MAPTKMT2AKIF11RAB9ACYP1A2
SCHEMBL6803588 0.82 HDAC3 (0.50) MAPTKMT2AKIF11ALDH1A1NPC1
SCHEMBL6093333 0.81 MAPT (0.49) MAPTKMT2AALDH1A1CYP1A2CYP3A4
SCHEMBL1819683 0.81 GPR52 (0.41) MAPTKMT2AALDH1A1NPC1RAB9A
SCHEMBL29501747 0.80 EDNRB (0.44) KMT2AOPRM1LMNACHRM2KCNH2
SCHEMBL1818243 0.80 POLB (0.40) MAPTKMT2AKIF11ALDH1A1NPC1
SCHEMBL12505244 0.79 KMT2A (0.52) MAPTKMT2AKIF11CYP2C19HIF1A
SCHEMBL22758087 0.79 MAPT (0.52) MAPTKMT2AKIF11CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 MAPT 1533/4885KMT2A 58/4885KIF11 1407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.